IN2014CN03580A - - Google Patents
Info
- Publication number
- IN2014CN03580A IN2014CN03580A IN3580CHN2014A IN2014CN03580A IN 2014CN03580 A IN2014CN03580 A IN 2014CN03580A IN 3580CHN2014 A IN3580CHN2014 A IN 3580CHN2014A IN 2014CN03580 A IN2014CN03580 A IN 2014CN03580A
- Authority
- IN
- India
- Prior art keywords
- block copolymer
- chain segment
- based drug
- amino acid
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
- A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/40—Polyamides containing oxygen in the form of ether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/42—Polyamides containing atoms other than carbon, hydrogen, oxygen, and nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561022P | 2011-11-17 | 2011-11-17 | |
| PCT/JP2012/079897 WO2013073697A1 (ja) | 2011-11-17 | 2012-11-19 | フェニルボロン酸基が導入されたブロックコポリマーおよびその使用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03580A true IN2014CN03580A (fi) | 2015-10-09 |
Family
ID=48429749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3580CHN2014 IN2014CN03580A (fi) | 2011-11-17 | 2012-11-19 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9114177B2 (fi) |
| EP (1) | EP2781536B1 (fi) |
| JP (1) | JP5481614B2 (fi) |
| KR (1) | KR101912978B1 (fi) |
| CN (1) | CN104093768B (fi) |
| AU (1) | AU2012337721B2 (fi) |
| BR (1) | BR112014011831A2 (fi) |
| CA (1) | CA2853902A1 (fi) |
| ES (1) | ES2603632T3 (fi) |
| IN (1) | IN2014CN03580A (fi) |
| MX (1) | MX2014005540A (fi) |
| RU (1) | RU2014124333A (fi) |
| WO (1) | WO2013073697A1 (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012233171B2 (en) | 2011-03-31 | 2015-08-20 | Nanocarrier Co., Ltd. | Pharmaceutical composition containing block copolymer comprising boronic acid compound |
| EP2842546A4 (en) | 2012-04-27 | 2015-12-30 | Univ Tokyo | UNITARY STRUCTURE-TYPE PHARMACEUTICAL COMPOSITION FOR NUCLEIC ACID ADMINISTRATION |
| JPWO2015121924A1 (ja) * | 2014-02-12 | 2017-03-30 | アキュルナ株式会社 | ｍＲＮＡ送達用組成物 |
| JP6566936B2 (ja) * | 2014-05-08 | 2019-08-28 | 国立大学法人 東京大学 | 医薬組成物 |
| KR101891655B1 (ko) * | 2016-05-17 | 2018-08-24 | 기초과학연구원 | 페닐보론산이 결합된 고분자를 포함하는 약물 전달체 |
| CN109642024A (zh) * | 2016-08-02 | 2019-04-16 | 日本化药株式会社 | 主动靶向型高分子衍生物、包含该高分子衍生物的组合物以及它们的用途 |
| EP3501544B1 (en) * | 2016-08-22 | 2021-07-28 | Tokyo Institute of Technology | Ligand capable of multivalently binding to glutamine transporter, and composition comprising same |
| JP6644326B2 (ja) * | 2017-08-31 | 2020-02-12 | 国立大学法人 東京大学 | 核酸搭載ユニット型ポリイオンコンプレックス |
| KR102075476B1 (ko) * | 2017-12-29 | 2020-02-10 | 포항공과대학교 산학협력단 | 페닐보론산이 결합된 고분자를 포함하는 하이드로겔 |
| EP3978078A4 (en) | 2019-05-29 | 2023-08-02 | Tokyo Institute of Technology | COMPLEX, MEDICINE, THERAPEUTIC AGENT FOR CANCER, KIT AND CONJUGATE |
| BR112022004981A2 (pt) | 2019-09-20 | 2022-06-21 | Glyscend Inc | Ácido fenilborônico substituído contendo polímeros e métodos de uso |
| CN114163591B (zh) * | 2021-11-29 | 2023-08-01 | 南方医科大学 | 一种嵌段共聚物、嵌段共聚物载药胶束及其制备方法和应用 |
| CN114533669B (zh) * | 2022-01-18 | 2022-11-04 | 武汉大学 | 一种口腔护理组合物及其制备方法和应用 |
| CN114632145B (zh) * | 2022-03-07 | 2024-02-27 | 浙江大学 | 一种负载胰岛素的苯硼酸/脂肪酸双改性ε-聚赖氨酸颗粒及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3257029B2 (ja) | 1992-04-22 | 2002-02-18 | 日本油脂株式会社 | フェニルボロン酸誘導体及び製造方法 |
| JPH083172A (ja) | 1994-06-15 | 1996-01-09 | Nippon Oil & Fats Co Ltd | フェニルボロン酸誘導体および製造方法 |
| US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| JP2002179683A (ja) | 2000-12-13 | 2002-06-26 | Japan Science & Technology Corp | ポリアミノ酸誘導体から成る核酸関連物質反応試薬 |
| NZ575964A (en) | 2006-10-19 | 2011-12-22 | Nanocarrier Co Ltd | Block copolymer for drug complex and pharmaceutical composition |
| EP2131814A4 (en) | 2007-02-26 | 2011-08-03 | Wisconsin Alumni Res Found | POLYMIC MICROMS FOR THE RELEASE OF ACTIVE COMPOUNDS |
| US8980241B2 (en) | 2008-05-02 | 2015-03-17 | University Of Tsukuba | Polymerized cyclic nitroxide radical compound and use thereof |
| AU2009246321A1 (en) | 2008-05-13 | 2009-11-19 | Phaserx, Inc. | Polymeric carrier |
| KR101468268B1 (ko) | 2008-07-29 | 2014-12-02 | 나노캬리아 가부시키가이샤 | 약물 내포 액티브 타겟형 고분자 미셀, 의약 조성물 |
| EP2323628B1 (en) | 2008-08-13 | 2022-04-13 | California Institute of Technology | Carrier nanoparticles and related compositions, methods and systems |
| WO2010114770A1 (en) | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| JP5622188B2 (ja) | 2010-01-05 | 2014-11-12 | 独立行政法人物質・材料研究機構 | フェニルボロン酸系単量体及びフェニルボロン酸系重合体 |
| JP2011173960A (ja) | 2010-02-23 | 2011-09-08 | Univ Of Tsukuba | 高分子ミセル型光刺激応答性一酸化窒素供与体 |
| AU2012233171B2 (en) | 2011-03-31 | 2015-08-20 | Nanocarrier Co., Ltd. | Pharmaceutical composition containing block copolymer comprising boronic acid compound |
-
2012
- 2012-11-19 RU RU2014124333/04A patent/RU2014124333A/ru not_active Application Discontinuation
- 2012-11-19 BR BR112014011831A patent/BR112014011831A2/pt not_active IP Right Cessation
- 2012-11-19 CN CN201280056639.0A patent/CN104093768B/zh not_active Expired - Fee Related
- 2012-11-19 WO PCT/JP2012/079897 patent/WO2013073697A1/ja active Application Filing
- 2012-11-19 JP JP2013529476A patent/JP5481614B2/ja not_active Expired - Fee Related
- 2012-11-19 ES ES12850688.8T patent/ES2603632T3/es active Active
- 2012-11-19 MX MX2014005540A patent/MX2014005540A/es unknown
- 2012-11-19 KR KR1020147013186A patent/KR101912978B1/ko active IP Right Grant
- 2012-11-19 IN IN3580CHN2014 patent/IN2014CN03580A/en unknown
- 2012-11-19 CA CA2853902A patent/CA2853902A1/en not_active Abandoned
- 2012-11-19 US US14/358,816 patent/US9114177B2/en not_active Expired - Fee Related
- 2012-11-19 AU AU2012337721A patent/AU2012337721B2/en not_active Ceased
- 2012-11-19 EP EP12850688.8A patent/EP2781536B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2781536B1 (en) | 2016-08-17 |
| ES2603632T3 (es) | 2017-02-28 |
| US20150051347A1 (en) | 2015-02-19 |
| CN104093768A (zh) | 2014-10-08 |
| AU2012337721B2 (en) | 2015-12-10 |
| BR112014011831A2 (pt) | 2017-05-09 |
| CN104093768B (zh) | 2016-09-21 |
| RU2014124333A (ru) | 2015-12-27 |
| WO2013073697A1 (ja) | 2013-05-23 |
| AU2012337721A1 (en) | 2014-05-22 |
| KR101912978B1 (ko) | 2018-10-29 |
| EP2781536A1 (en) | 2014-09-24 |
| CA2853902A1 (en) | 2013-05-23 |
| JP5481614B2 (ja) | 2014-04-23 |
| JPWO2013073697A1 (ja) | 2015-04-02 |
| EP2781536A4 (en) | 2015-06-10 |
| KR20140106511A (ko) | 2014-09-03 |
| US9114177B2 (en) | 2015-08-25 |
| MX2014005540A (es) | 2014-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03580A (fi) | ||
| TN2012000369A1 (en) | 5-alkynyl-pyrimidines | |
| MX2015003653A (es) | Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj. | |
| IN2012DN02737A (fi) | ||
| MY165908A (en) | Heterocyclic compound and use thereof | |
| MX341732B (es) | Inhibidores de la demetilasa lsd1 basados en arilciclopropilamina y sus usos médicos. | |
| UA117098C2 (uk) | Сполука, що містить модифікований олігонуклеотид | |
| MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| MY160552A (en) | Low protein infant formula with increased essential amino acids | |
| EP2381957A4 (en) | THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM LIMITING LUBRICATION | |
| MY166789A (en) | Arginine salts and their uses for the treatment of illnesses in the oral cavity | |
| MX341565B (es) | 3-amino-piridinas como agonistas de receptor de acido biliar acoplado a proteina g1 (gpbar1). | |
| MX352245B (es) | Formulacion farmaceutica que comprende una droga biofarmaceutica. | |
| MX347734B (es) | Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas. | |
| GEP20166488B (en) | Co-crystals and salts of ccr3-inhibitors | |
| UA109037C2 (uk) | Триазолопіридини | |
| TW201129554A (en) | 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds | |
| GEP20166448B (en) | Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate | |
| MX2010009837A (es) | Tiazolil-dihidro-indazoles. | |
| MX2011011021A (es) | 5-alquinil-piridinas. | |
| TR201905060T4 (tr) | Fibroz için profilaktik ya da terapötik ajan. | |
| MX2013013403A (es) | Modificaciones cristalinas estables de cloruro de dotap. | |
| IN2012DN06600A (fi) | ||
| MX2011011065A (es) | Tia-triaza-ciclopentazulenos como inhibidores de quinasas p13 para el tratamiento del cancer. | |
| TN2010000408A1 (en) | Thiazolyl-dihydro-indazoles |